These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16793202)

  • 1. A new mucin antibody/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma.
    Bamrungphon W; Prempracha N; Bunchu N; Rangdaeng S; Sandhu T; Srisukho S; Boonla C; Wongkham S
    Cancer Lett; 2007 Mar; 247(2):301-8. PubMed ID: 16793202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of serum MUC5AC mucin in patients with cholangiocarcinoma.
    Boonla C; Wongkham S; Sheehan JK; Wongkham C; Bhudhisawasdi V; Tepsiri N; Pairojkul C
    Cancer; 2003 Oct; 98(7):1438-43. PubMed ID: 14508831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel serum carbohydrate marker on mucin 5AC: values for diagnostic and prognostic indicators for cholangiocarcinoma.
    Silsirivanit A; Araki N; Wongkham C; Pairojkul C; Narimatsu Y; Kuwahara K; Narimatsu H; Wongkham S; Sakaguchi N
    Cancer; 2011 Aug; 117(15):3393-403. PubMed ID: 21287531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures.
    Lempinen M; Isoniemi H; Mäkisalo H; Nordin A; Halme L; Arola J; Höckerstedt K; Stenman UH
    J Hepatol; 2007 Nov; 47(5):677-83. PubMed ID: 17640760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum MUC5AC mucin as a potential marker for cholangiocarcinoma.
    Wongkham S; Sheehan JK; Boonla C; Patrakitkomjorn S; Howard M; Kirkham S; Sripa B; Wongkham C; Bhudhisawasdi V
    Cancer Lett; 2003 May; 195(1):93-9. PubMed ID: 12767517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma.
    Uenishi T; Yamazaki O; Tanaka H; Takemura S; Yamamoto T; Tanaka S; Nishiguchi S; Kubo S
    Ann Surg Oncol; 2008 Feb; 15(2):583-9. PubMed ID: 17955299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mucin hypersecreting cholangiocarcinoma].
    Jeen YM; Jin SY
    Korean J Hepatol; 2008 Dec; 14(4):532-6. PubMed ID: 19119249
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.
    Higashi M; Yonezawa S; Ho JJ; Tanaka S; Irimura T; Kim YS; Sato E
    Hepatology; 1999 Dec; 30(6):1347-55. PubMed ID: 10573510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of bile and serum mucin5AC in cholangiocarcinoma: diagnostic performance and biologic significance.
    Danese E; Ruzzenente O; Ruzzenente A; Iacono C; Bertuzzo F; Gelati M; Conci S; Bendinelli S; Bonizzato G; Guglielmi A; Salvagno GL; Lippi G; Guidi GC
    Surgery; 2014 Nov; 156(5):1218-24. PubMed ID: 25151557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of serum tumour M2-PK and CA19-9 detection in the diagnosis of cholangiocarcinoma.
    Li YG; Zhang N
    Dig Liver Dis; 2009 Aug; 41(8):605-8. PubMed ID: 19168405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of MUC mucin in cholangiocarcinoma.
    Mall AS; Tyler MG; Ho SB; Krige JE; Kahn D; Spearman W; Myer L; Govender D
    Pathol Res Pract; 2010 Dec; 206(12):805-9. PubMed ID: 20947262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
    Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wisteria floribunda agglutinin-positive mucin 1 is a sensitive biliary marker for human cholangiocarcinoma.
    Matsuda A; Kuno A; Kawamoto T; Matsuzaki H; Irimura T; Ikehara Y; Zen Y; Nakanuma Y; Yamamoto M; Ohkohchi N; Shoda J; Hirabayashi J; Narimatsu H
    Hepatology; 2010 Jul; 52(1):174-82. PubMed ID: 20578261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis.
    Sawanyawisuth K; Silsirivanit A; Kunlabut K; Tantapotinan N; Vaeteewoottacharn K; Wongkham S
    Parasitol Int; 2012 Mar; 61(1):151-4. PubMed ID: 21784171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour.
    Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
    Histopathology; 2006 Jul; 49(1):35-44. PubMed ID: 16842244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study.
    Lumachi F; Lo Re G; Tozzoli R; D'Aurizio F; Facomer F; Chiara GB; Basso SM
    Anticancer Res; 2014 Nov; 34(11):6663-7. PubMed ID: 25368272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of biliary fibronectin for diagnosis of cholangiocarcinoma.
    Chen CY; Lin XZ; Tsao HC; Shiesh SC
    Hepatogastroenterology; 2003; 50(52):924-7. PubMed ID: 12845951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
    Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
    Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periostin, a matrix protein, has potential as a novel serodiagnostic marker for cholangiocarcinoma.
    Fujimoto K; Kawaguchi T; Nakashima O; Ono J; Ohta S; Kawaguchi A; Tonan T; Ohshima K; Yano H; Hayabuchi N; Izuhara K; Sata M
    Oncol Rep; 2011 May; 25(5):1211-6. PubMed ID: 21347516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of apolipoprotein A-I as a potential biomarker for cholangiocarcinoma.
    Wang X; Dai S; Zhang Z; Liu L; Wang J; Xiao X; He D; Liu B
    Eur J Cancer Care (Engl); 2009 Nov; 18(6):625-35. PubMed ID: 19486127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.